nowvaccineExisting can prevent serious illnesses that require hospitalization. and reduce the mortality rate but its efficiency decreases whenmutant virus
Stella Kyriakids, European Commissioner for Health said in a statement “It is very important that the elderly 60 years and older and vulnerable groups receivebooster vaccineSecond needle as quickly as possible.”
byEuropean health organizationRecommended since April that the second booster vaccine should only be given to elderly people 80 years of age and older and vulnerable groups only
Latest advice It is expected to make it easier to make decisions about expediting national vaccinations. where vaccination has slowed to a near halt in the past few months.
Dr Andrea Ammon, director of the European Centers for Disease Control and Prevention, said: “We now find that the detection rateCovid-19 infected people Increased number of patients hospitalized and more ICUs and the spread of COVID in many countries is full ofOmikronsubspecies BA.5”
vaccine makerModerna and manufacturerPfizeratBioEntech A new batch of vaccines developed against the Omicron virus is being tested. BA.1
even they said These vaccines can provide immunity against omikron. BA.1 and other mutant viruses, but respond to virus strains. BA.4 and lower BA.5
European Medicines Agency The (EMA) is testing both modified vaccines. A new vaccine is expected to be approved by September.
Emer Cook, Executive Director of the European Medicines Agency, said: “It is now very important that a licensed vaccine be used as a second booster for the most vulnerable patients.”
Proofreading….Suree Silawong